"Advanced Urology Institute is a professional corporation of medical doctors (M.D.'s) who are board-certified and qualified in the surgical sub-specialty of urology. The physicians of Advanced Urology Institute in Daytona Beach, FL recognized locally for their medical expertise and hold key positions in the urological community at both the state and national level. Leadership is a core value of our practice and an honor met with dedication, integrity and commitment. Through innovation and collaboration our practice continues to be recognized for providing leading-edge urology and patient-centered care"

During the past decade, Advanced Urology Institute conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Urology Institute" #1 sponsor was "Allena Pharmaceuticals" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "GTx" with 2 trials sponsored, "NeoTract, Inc." with 2 trials sponsored and "Novartis Pharmaceuticals" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Urology Institute" #1 collaborator was "ClinLogix. LLC" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "H2O Clinical LLC" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Urology Institute" are "Prostate Cancer" (7 trials), "Benign Prostatic Hyperplasia" (3 trials), "Bladder Cancer" (2 trials), "Dietary Hyperoxaluria" (2 trials) and "Enteric Hyperoxaluria" (2 trials). Many other conditions were trialed in "Advanced Urology Institute" in a lesser frequency.

Most popular intervention types in "Advanced Urology Institute" are "Drug" (17 trials), "Device" (6 trials), "Other" (4 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "ALLN-177" (2 trials), "Niraparib" (2 trials), "Prednisone" (2 trials) and "ADXBLADDER" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Urology Institute" are 19 trials for "Male" genders, 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Advanced Urology Institute". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Advanced Urology Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Urology Institute, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".